Search Result
Results for "
4(1H
" in MedChemExpress (MCE) Product Catalog:
4
Biochemical Assay Reagents
9
Isotope-Labeled Compounds
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-W037619
-
|
|
Biochemical Assay Reagents
|
Neurological Disease
Cancer
|
|
Pteridine-2,4 (1H,3H)-dione is a pteridine derivative (xanthopterin) and a sulfur-containing pteridine compound (2,4-dimercaptopyrimidine). Pteridine-2,4 (1H,3H)-dione possesses metal-binding ability, and forms closed-shell (ionic) interactions with palladium via sulfur and nitrogen atoms. Pteridine-2,4 (1H,3H)-dione derivates can be used in studies related to neuroblastoma, glioma and breast cancer .
|
-
-
- HY-W075276
-
|
|
MOFs
|
Others
|
|
4-((1H-Pyrazol-1-yl)methyl)benzoic acid (4-(1H-pyrazol-1-ylmethyl)benzoic acid) is a metal-organic framework (MOF).
|
-
-
- HY-W017713
-
|
1,4-Di(1H-pyrazol-4-yl)benzene
|
MOFs
|
Others
|
|
4-[4-(1H-Pyrazol-4-yl)phenyl]-1H-pyrazole (1,4-Di(1H-pyrazol-4-yl)benzene) is a metal-organic framework (MOF).
|
-
-
- HY-W015462
-
|
4-(1H-Imidazol-1-yl)aniline
|
HSV
|
Infection
|
|
LANA-IN-1 (compound 8) is an N-acetyl-derived LANA inhibitor with antiviral activity against herpesvirus. In fluorescence assays using the LANA probe LBS2, 1 mM LANA-IN-1 shows an inhibition rate of 32%. LANA-IN-1 may inhibit the interaction between LANA and the viral genome .
|
-
-
- HY-W052191
-
|
|
MOFs
|
Others
|
|
4-(1H-Imidazol-2-yl)pyridine is a metal-organic framework (MOF).
|
-
-
- HY-34840
-
|
|
Drug Intermediate
|
Others
|
|
6-Hydrazinyl-3-methylpyrimidine-2,4(1H,3H)-dione is a drug intermediate for synthesis of various active compounds.
|
-
-
- HY-N9530
-
-
-
- HY-W112721
-
|
4-(1H-Pyrazol-4-yl)-1H-pyrazole
|
MOFs
|
Others
|
|
1H,1'H-4,4'-Bipyrazole (4-(1H-Pyrazol-4-yl)-1H-pyrazole) is a metal-organic framework (MOF).
|
-
-
- HY-78248
-
|
|
Biochemical Assay Reagents
|
Others
|
|
4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
-
- HY-N1638
-
|
|
Monoamine Oxidase
|
Neurological Disease
|
|
1-Methyl-2-undecyl-4(1H)-quinolone is a potent, irreversible and selective inhibitor of type B monoamine oxidase (MAO-B). 1-Methyl-2-undecyl-4(1H)-quinolone shows a selective inhibition of MAO-B activity with the IC50 and Ki values of 15.3 μM and 9.91 μM, respectively, but did not inhibit type A MAO (MAO-A) activity. Methyl-2-undecyl-4(1H)-quinolone, as a quinolone alkaloid, is isolated from fresh leaves and fruits of Evodia rutaecarpa HOOK. f. et THOMS .
|
-
-
- HY-168698
-
|
|
PROTAC Linkers
|
Cancer
|
|
(4-(1H-1,2,3-Triazol-4-yl)phenyl)methanol is a PROTAC Linker. (4-(1H-1,2,3-Triazol-4-yl)phenyl)methanol can be used to synthesize PROTAC Setidegrasib (HY-148273) .
|
-
-
- HY-N1637
-
|
|
Bacterial
|
Infection
Cancer
|
|
1-Methyl-2-pentyl-4(1H)-quinolinone, a quinolone alkaloid isolated from the fruits of Evodia Rutaecarpa, possesses antibacterial and cytotoxic activities for cancer cells .
|
-
-
- HY-N10456
-
|
|
Bacterial
|
Infection
|
|
1-Methyl-2-(8E)-8-tridecenyl-4(1H)-quinolinone is a potent antibacterial agent with an MIC50 value of 22 µM and an MIC90 value of 50 µM for Helicobacter pyloriStrain 51. 1-Methyl-2-(8E)-8-tridecenyl-4(1H)-quinolinone has the potential for the research of gastric and duodenal ulcers .
|
-
-
- HY-N0968
-
|
|
Others
|
Others
|
|
1-Methyl-2-[(Z)-6-undecenyl]-4(1H)-quinolone, as a colorless oil, is a quinolone alkaloid isolated from the fruit of Evodia rutaecarpa BENTHAM (Rutaceae) .
|
-
-
- HY-W741652
-
-
-
- HY-N9520
-
|
|
Angiotensin Receptor
|
Cardiovascular Disease
Endocrinology
|
|
Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone9 is an antagonist of angiotensin II receptor (IC50=48.2 μM). Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone9 is a quinolone alkaloid from Evodia rutaecarpa .
|
-
-
- HY-N10907
-
|
|
Bacterial
|
Infection
|
|
4(1H)-Quinolinone, 1-methyl-2-(5Z)-5-undecen-1-yl- (compound 2) is a quinolone alkaloid that can be isolated from Cnidium. 4(1H)-Quinolinone, 1-methyl-2-(5Z)-5-undecen-1-yl- has methicillin-resistant Staphylococcus aureus (MRSA) activity, with MIC values of 32 μg/mL (ATCC 33591) and 16 μM/mL (ATCC 25923), respectively .
|
-
-
- HY-154741S
-
-
-
- HY-154325
-
|
|
Nucleoside Antimetabolite/Analog
|
Cancer
|
|
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-4(1H)-pyrimidinone is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
-
- HY-152603
-
|
|
Nucleoside Antimetabolite/Analog
|
Others
|
|
2-Amino-1-β-D-arabinofuranosyl-5-methyl-4(1H)-pyrimidinone is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
-
- HY-152853
-
|
|
Nucleoside Antimetabolite/Analog
|
Others
|
|
3-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
-
- HY-154663
-
|
|
Nucleoside Antimetabolite/Analog
|
Cancer
|
|
1-β-D-Arabinofuranosyl-5-bromo-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
-
- HY-W555382S
-
|
2-Nonylquinolin-4(1H)-one-d4
|
Isotope-Labeled Compounds
HCV
|
Infection
|
|
Pseudane IX-d4 (2-Nonylquinolin-4(1H)-one-d4) is deuterium labeled Pseudane IX. Pseudane IX, a compound isolated from the leaves of Ruta angustifolia, has strong anti-HCV activity with an IC50 value of 1.4 μg/mL. Pseudane IX reduces HCV RNA replication and viral protein synthesis levels .
|
-
-
- HY-154335
-
|
|
Nucleoside Antimetabolite/Analog
|
Cancer
|
|
1-(3-Deoxy-3-fluoro-β-D-xylofuranosyl)-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
-
- HY-152676
-
|
|
Nucleoside Antimetabolite/Analog
|
Others
|
|
1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethyl-2,4(1H,3H)-pyrimidinedione is a thymidine analogue. Analogs of this series have insertional activity towards replicated DNA. They can be used to label cells and track DNA synthesis .
|
-
-
- HY-W751834
-
|
NSC 99321-13C3; 6-Amino-5-nitrouracil-13C3
|
Isotope-Labeled Compounds
|
Others
|
|
6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione- 13C3 (NSC 99321- 13C3) is the 13C-labeled 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione (HY-W016913).
|
-
-
- HY-154652
-
|
|
Nucleoside Antimetabolite/Analog
|
Cancer
|
|
1-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents .
|
-
-
- HY-154613
-
|
|
Nucleoside Antimetabolite/Analog
|
Cancer
|
|
(2R-cis)-5-[Tetrahydro-5-(hydroxymethyl)-4-oxo-2-furanyl]-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
-
- HY-W768482
-
|
2-Amino-6-hydroxy-1H-pyrimidin-4-one-13C2; 2-Amino-4,6-dihydroxypyrimidine-13C2
|
Isotope-Labeled Compounds
|
Others
|
|
2-Amino-6-hydroxypyrimidin-4(1H)-one- 13C2 (2-Amino-6-hydroxy-1H-pyrimidin-4-one- 13C2) is the 13C-labeled 2-Amino-6-hydroxypyrimidin-4(1H)-one (HY-Y0559).
|
-
-
- HY-W023713
-
|
4-(1H-Pyrazol-3-yl)benzoic acid
|
MOFs
|
Others
|
|
4-(1H-Pyrazol-5-yl)benzoic acid (4-(1H-Pyrazol-3-yl)benzoic acid) is a metal-organic framework (MOF).
|
-
-
- HY-W112141
-
|
|
MOFs
|
Others
|
|
N-(4-(1H-Imidazol-1-yl)phenyl)-4-(1H-imidazol-1-yl)-n-phenylaniline is a metal-organic framework (MOF).
|
-
-
- HY-W075288
-
|
|
MOFs
|
Others
|
|
4-(1H-Imidazol-1-yl)benzoic acid is a metal-organic framework (MOF).
|
-
-
- HY-W051244
-
|
|
MOFs
|
Others
|
|
4-(1H-Pyrazol-3-yl)pyridine is a metal-organic framework (MOF).
|
-
-
- HY-W019096
-
|
|
MOFs
|
Others
|
|
4-(1H-Pyrazol-4-yl)pyridine is a metal-organic framework (MOF).
|
-
-
- HY-W090282
-
|
|
MOFs
|
Others
|
|
4-(1H-Imidazol-5-yl)pyridine is a metal-organic framework (MOF).
|
-
-
- HY-W075074
-
|
Tetrakis[4-(1H-Imidazol-1-yl)phenyl]ethylene
|
MOFs
|
Others
|
|
1,1,2,2-Tetrakis(4-(1H-imidazol-1-yl)phenyl)ethene(Tetrakis[4-(1H-Imidazol-1-yl)phenyl]ethylene) is a metal-organic framework (MOF).
|
-
-
- HY-402321
-
|
|
Others
|
Others
|
|
2-Octyl-4(1H)-quinolone (Compound 14) is a quinolinone alkaloid that can be isolated from Ruta graveolens .
|
-
-
- HY-W075237
-
|
5-[4-(1H-Imidazol-1-yl)phenyl]-1H-pyrazole
|
MOFs
|
Others
|
|
3-(4-(1H-Imidazol-1-yl)phenyl)-1H-pyrazole (5-[4-(1H-Imidazol-1-yl)phenyl]-1H-pyrazole) is a metal-organic framework (MOF).
|
-
-
- HY-W456450
-
|
|
MOFs
|
Others
|
|
4-((1H-Imidazol-1-yl)methyl)pyridine is a metal-organic framework (MOF).
|
-
-
- HY-N1636
-
|
|
Monoamine Oxidase
|
Neurological Disease
|
|
1-Methyl-2-nonyl-4(1H)-quinolone, a quinolone alkaloid, is a potent and selective MAO-B (monoamine oxidase) inhibitor. 1-Methyl-2-nonyl-4(1H)-quinolone exhibites inhibitory activity on leukotriene biosynthesis, with an IC50 of 12.1 μM .
|
-
-
- HY-W037619R
-
-
-
- HY-W112186
-
|
|
MOFs
|
Others
|
|
Tris(4-(1H-pyrazol-4-yl)phenyl)amine is a metal-organic framework (MOF).
|
-
-
- HY-W456445
-
|
|
MOFs
|
Others
|
|
Bis(4-(1H-imidazol-1-yl)phenyl)methanone is a metal-organic framework (MOF).
|
-
-
- HY-W1049876
-
|
|
MOFs
|
Others
|
|
2-Methoxy-4-(1H-pyrazol-4-yl)benzoic acid is a metal-organic framework (MOF).
|
-
-
- HY-N16462
-
|
|
Bacterial
|
Infection
|
|
2-(2-Heptenyl)-3-methyl-4(1H)-quinolone is a quinoline alkaloid found in Burkholderia sp. VY81. 2-(2-Heptenyl)-3-methyl-4(1H)-quinolone is promising for research of bacterial diseases in rice (e.g., soft rot) and other plant pathogens (e.g., Pythium ultimum, Fusarium oxysporum) .
|
-
-
- HY-W112648
-
|
Tris[4-(1H-pyrazol-4-yl)phenyl]-1,3,5-triazine
|
MOFs
|
Others
|
|
2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine(Tris[4-(1H-pyrazol-4-yl)phenyl]-1,3,5-triazine) is a metal-organic framework (MOF).
|
-
-
- HY-W002957
-
|
|
MOFs
|
Others
|
|
4-(1H-1,2,4-triazol-1-yl)benzoic acid is a metal-organic framework (MOF).
|
-
-
- HY-W543327
-
|
|
MOFs
|
Others
|
|
4-(1H-1,2,3-Triazol-5-yl)benzaldehyde is a metal-organic framework (MOF).
|
-
-
- HY-W1049875
-
|
|
MOFs
|
Others
|
|
2,6-Difluoro-4-(1H-pyrazol-4-yl)benzoic acid is a metal-organic framework (MOF).
|
-
-
- HY-W077690
-
|
|
Bacterial
|
Infection
|
|
3-(2-Hydroxyethyl)quinazoline-2,4(1H,3H)-dione is an metal chelating agent and anti-bacterial agent. 3-(2-Hydroxyethyl)quinazoline-2,4(1H,3H)-dione shows inhibitory activity against gram-positive and gram-negative bacterial strains .
|
-
- HY-W075338
-
|
|
MOFs
|
Others
|
|
4,4',4''-(1H-Imidazole-2,4,5-triyl)tripyridine is a metal-organic framework (MOF).
|
-
- HY-W075591
-
|
|
MOFs
|
Others
|
|
4,4',4''-(1H-Imidazole-2,4,5-triyl)tribenzoic acid is a metal-organic framework (MOF).
|
-
- HY-W075289
-
|
4-(4-Pyrazolyl)benzoic Acid
|
MOFs
|
Others
|
|
4-(1H-Pyrazol-4-yl)benzoic acid (4-(4-Pyrazolyl)benzoic Acid) is a metal-organic framework (MOF).
|
-
- HY-W075275
-
|
|
MOFs
|
Others
|
|
4-((1H-1,2,4-Triazol-1-yl)methyl)benzoic acid is a metal-organic framework (MOF).
|
-
- HY-W088324
-
|
2,4,6-Tris[4-(1H-imidazole-1-yl)phenyl]-1,3,5-triazine
|
MOFs
|
Others
|
|
2,4,6-Tris[4-(1H-imidazol-1-yl)-phenyl]-1,3,5-triazine (2,4,6-Tris[4-(1H-imidazole-1-yl)phenyl]-1,3,5-triazine) is a metal-organic framework (MOF).
|
-
- HY-120021
-
|
|
Drug Intermediate
|
Others
|
|
tert-Butyl 4-(1H-indol-4-yl)piperazine-1-carboxylate is a synthetic intermediate useful for pharmaceutical synthesis..
|
-
- HY-W456587
-
|
|
MOFs
|
Others
|
|
4'-(1H-Imidazol-1-yl)-[1,1'-biphenyl]-4-carboxylic acid is a metal-organic framework (MOF).
|
-
- HY-W075608
-
|
|
MOFs
|
Others
|
|
4,4'-(1H-1,2,4-Triazole-3,5-diyl)dibenzoic acid is a metal-organic framework (MOF).
|
-
- HY-W543659
-
|
|
MOFs
|
Others
|
|
2,4,6-Tris(4-(1H-imidazol-1-yl)phenyl)pyridine is a metal-organic framework (MOF).
|
-
- HY-33426
-
|
4-(Imidazol-2-yl)benzoic acid
|
MOFs
|
Others
|
|
4-(1H-Imidazol-2-yl)benzoic acid (4-(Imidazol-2-yl)benzoic acid) is a metal-organic framework (MOF).
|
-
- HY-W187606
-
|
4-Imidazol-1-yl-pyridine
|
MOFs
|
Others
|
|
4-(1h-Imidazol-1-yl)pyridine (4-Imidazol-1-yl-pyridine) is a metal-organic framework (MOF).
|
-
- HY-W042977
-
|
4-(1H-Imidazol-1-ylmethyl)benzoic acid
|
MOFs
|
Others
|
|
4-(Imidazol-1-ylmethyl)benzoic acid (4-(1H-Imidazol-1-ylmethyl)benzoic acid) is a metal-organic framework (MOF).
|
-
- HY-W112072
-
|
|
MOFs
|
Others
|
|
Tris(4-(1H-1,2,4-triazol-1-yl)phenyl)amine is a metal-organic framework (MOF).
|
-
- HY-W586933
-
|
|
MOFs
|
Others
|
|
4-(1H-1,2,4-Triazol-1-yl)-1,3-benzenedicarboxylic acid is a metal-organic framework (MOF).
|
-
- HY-W112495
-
|
|
MOFs
|
Others
|
|
4'-(1H-Imidazol-1-yl)[1,1'-biphenyl]-3,5-dicarboxylic acid is a metal-organic framework (MOF).
|
-
- HY-W456446
-
|
|
MOFs
|
Others
|
|
2,6-Bis(4-(1H-imidazol-1-yl)phenyl)-4-phenylpyridine is a metal-organic framework (MOF).
|
-
- HY-W112506
-
|
Letrozole Intermediate
|
MOFs
|
Others
|
|
4-((1H-1,2,4-Triazol-3-yl)methyl)benzonitrile (Letrozole Intermediate) is a metal-organic framework (MOF).
|
-
- HY-W578280
-
|
|
MOFs
|
Others
|
|
1,1,2,2-Tetrakis(4-(1H-pyrazol-4-yl)phenyl)ethene is a metal-organic framework (MOF).
|
-
- HY-W075427
-
|
|
MOFs
|
Others
|
|
5,10,15,20-Tetrakis(4-(1H-imidazol-1-yl)phenyl)porphyrin is a metal-organic framework (MOF).
|
-
- HY-W856092
-
|
|
MOFs
|
Others
|
|
5,10,15,20-Tetrakis(4-(1H-pyrazol-4-yl)phenyl)porphyrin is a metal-organic framework (MOF).
|
-
- HY-W543661
-
|
|
MOFs
|
Others
|
|
1,1,2,2-Tetrakis(4-(1H-pyrazol-3-yl)phenyl)ethene is a metal-organic framework (MOF).
|
-
- HY-W095820R
-
|
|
Reference Standards
|
|
|
6-((3-Chloropropyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione (Standard) is the analytical standard of 6-((3-Chloropropyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione. This product is intended for research and analytical applications.
|
-
- HY-W112496
-
|
|
MOFs
|
Others
|
|
4-(1H-Imidazo[4,5-f][1,10]phenanthrolin-2-yl)benzoic acid is a metal-organic framework (MOF).
|
-
- HY-W456336
-
|
|
MOFs
|
Others
|
|
4,4'-(1H,1'H-[2,2'-Biimidazole]-1,1'-diyl)dibenzoic acid is a metal-organic framework (MOF).
|
-
- HY-W456447
-
|
|
MOFs
|
Others
|
|
2,6-Bis(4-(1H-imidazol-1-yl)phenyl)-4,4'-bipyridine is a metal-organic framework (MOF).
|
-
- HY-115271
-
|
Methyl 4-(1H-imidazol-1-yl)benzoate
|
MOFs
|
Others
|
|
1-(4-Methoxycarbonylphenyl)-1H-imidazole (Methyl 4-(1H-imidazol-1-yl)benzoate) is a metal-organic framework (MOF).
|
-
- HY-W071559
-
|
|
Drug Intermediate
|
Others
|
|
6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4(1H)-one is a drug intermediate for synthesis of various active compounds.
|
-
- HY-W112843
-
|
|
MOFs
|
Others
|
|
1,1,2,2-Tetrakis(4-(1H-benzo[d]imidazol-1-yl)phenyl)ethene is a metal-organic framework (MOF).
|
-
- HY-W543683
-
|
|
MOFs
|
Others
|
|
1,1,2,2-Tetrakis(4-(1H-benzo[d]imidazol-2-yl)phenyl)ethene is a metal-organic framework (MOF).
|
-
- HY-W075566
-
|
Tris[4-(1-imidazolyl)phenyl]amine
|
MOFs
|
Others
|
|
Tris(4-(1H-imidazol-1-yl)phenyl)amine(Tris[4-(1-imidazolyl)phenyl]amine) is a metal-organic framework (MOF).
|
-
- HY-W543687
-
|
|
MOFs
|
Others
|
|
2,4,6-Tris(4-(1H-tetrazol-5-yl)phenyl)-1,3,5-triazine is a metal-organic framework (MOF).
|
-
- HY-W112350
-
|
|
MOFs
|
Others
|
|
4-[4-(1H-Imidazol-1-yl)phenyl]-2,6-di(pyridin-4-yl)pyridine is a metal-organic framework (MOF).
|
-
- HY-W112447
-
|
Letrozole Diacid Impurity
|
MOFs
|
Others
|
|
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzoic acid] (Letrozole Diacid Impurity) is a metal-organic framework (MOF).
|
-
- HY-W1049879
-
|
|
MOFs
|
Others
|
|
4'-(1H-1,2,4-Triazol-1-yl)-[1,1'-biphenyl]-3,5-dicarboxylic acid is a metal-organic framework (MOF).
|
-
- HY-W543660
-
|
|
MOFs
|
Others
|
|
2,4,6-Tris(4-((1H-imidazol-1-yl)methyl)phenyl)-1,3,5-triazine is a metal-organic framework (MOF).
|
-
- HY-W112497
-
|
|
MOFs
|
Others
|
|
4-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-methylpyridin-1-ium iodide is a metal-organic framework (MOF).
|
-
- HY-W701580
-
|
6-Amino-3-methyluracil-d3
|
Isotope-Labeled Compounds
|
Others
|
|
6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione-d3 (6-Amino-3-methyluracil-d3) is the deuterium labeled 6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione (HY-W038777).
|
-
- HY-W034940
-
|
2,6-Di(2-pyridyl)-4(1H)-pyridone
|
MOFs
|
Others
|
|
2,6-Bis(pyridin-2-yl)-4-pyridone (2,6-Di(2-pyridyl)-4(1H)-pyridone) is a metal-organic framework (MOF).
|
-
- HY-183863
-
|
|
Biochemical Assay Reagents
|
Others
|
|
N-(4-(1H-Pyrazol-1-yl) butyl)-5-(furan-2-yl) isoxazole-3-carboxamide is a cell culture medium component used for the long-term expansion of granulocyte/macrophage progenitor cells in culture .
|
-
- HY-W456475
-
|
Tetrakis(4-(2H-tetrazol-5-yl)phenyl)methane
|
MOFs
|
Others
|
|
Tetrakis(4-(1H-tetrazol-5-yl)phenyl)methane (Tetrakis(4-(2H-tetrazol-5-yl)phenyl)methane) is a metal-organic framework (MOF).
|
-
- HY-W248994
-
|
4-[3-(4-Pyridyl)-1H-pyrazol-5-yl]pyridine
|
MOFs
|
Others
|
|
4,4'-(1H-Pyrazole-3,5-diyl)dipyridine (4-[3-(4-Pyridyl)-1H-pyrazol-5-yl]pyridine) is a metal-organic framework (MOF).
|
-
- HY-W112844
-
|
Tetrakis(4-triazolylphenyl)ethylene
|
MOFs
|
Others
|
|
1,1,2,2-Tetrakis(4-(1H-1,2,4-triazol-1-yl)phenyl)ethene(Tetrakis(4-triazolylphenyl)ethylene) is a metal-organic framework (MOF).
|
-
- HY-W249355
-
|
2-[4-(1H-Imidazol-2-yl)phenyl]-1H-imidazole
|
MOFs
|
Others
|
|
1,4-Di(1H-imidazol-2-yl)benzene (2-[4-(1H-Imidazol-2-yl)phenyl]-1H-imidazole) is a metal-organic framework (MOF).
|
-
- HY-W075554
-
|
1,1',1'',1'''-(Methanetetrayltetra-4,1-phenylene)tetrakis(1H-imidazole)
|
MOFs
|
Others
|
|
Tetrakis(4-(1H-imidazol-1-yl)phenyl)methane(1,1',1'',1'''-(Methanetetrayltetra-4,1-phenylene)tetrakis(1H-imidazole)) is a metal-organic framework (MOF).
|
-
- HY-W075701
-
|
|
MOFs
|
Others
|
|
4,4'-(5'-(4-(1H-Pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(1H-pyrazole) is a metal-organic framework (MOF).
|
-
- HY-W456468
-
|
|
MOFs
|
Others
|
|
1,1'-(5'-(4-(1H-Pyrrol-1-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(1H-pyrrole) is a metal-organic framework (MOF).
|
-
- HY-W112753
-
|
2-[4-(1H-Benzimidazol-2-yl)phenyl]-1H-benzimidazole
|
MOFs
|
Others
|
|
1,4-Bis(1H-benzo[d]imidazol-2-yl)benzene (2-[4-(1H-Benzimidazol-2-yl)phenyl]-1H-benzimidazole) is a metal-organic framework (MOF).
|
-
- HY-W352508
-
|
2,6-Di-pyridin-4-yl-3H-pyrimidin-4-one
|
MOFs
|
Others
|
|
2,6-Di(pyridin-4-yl)pyrimidin-4(1H)-one (2,6-Di-pyridin-4-yl-3H-pyrimidin-4-one) is a metal-organic framework (MOF).
|
-
- HY-W112953
-
|
1-(4-(1H-imidazol-1-yl)-2,5-dimethylphenyl)-1H-imidazole
|
MOFs
|
Others
|
|
1,1'-(2,5-Dimethyl-1,4-phenylene)bis(1H-imidazole) (1-(4-(1H-imidazol-1-yl)-2,5-dimethylphenyl)-1H-imidazole) is a metal-organic framework (MOF).
|
-
- HY-34495R
-
-
- HY-W075070
-
|
1,3,5-tris(4-(Imidazol-1-yl)phenyl)benzene
|
MOFs
|
Others
|
|
1,1'-(5'-(4-(1H-Imidazol-1-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(1H-imidazole)(1,3,5-tris(4-(Imidazol-1-yl)phenyl)benzene) is a metal-organic framework (MOF).
|
-
- HY-W095670
-
|
|
Drug Intermediate
|
Others
|
|
2,4,7-Trichloro-8-fluoropyridopyrimidine is a pyridopyrimidine synthetic intermediate of MRTX1133 (HY-134813), which can be used for the synthesis of non-covalent KRAS G12D inhibitors .
|
-
- HY-W555382
-
|
2-Nonylquinolin-4(1H)-one
|
HCV
|
Infection
|
|
Pseudane IX, a compound isolated from the leaves of Ruta angustifolia, has strong anti-HCV activity with an IC50 value of 1.4 μg/mL. Pseudane IX reduces HCV RNA replication and viral protein synthesis levels .
|
-
- HY-Y1050R
-
|
|
Reference Standards
|
|
|
2,5-Dihydroxy-6,7-dimethoxyquinazoline (Standard) is the analytical standard of 2,5-Dihydroxy-6,7-dimethoxyquinazoline. This product is intended for research and analytical applications.
|
-
- HY-W007695
-
|
4-Imidazolecarboxylic acid
|
Biochemical Assay Reagents
|
Others
|
|
1H-Imidazole-4-carboxylic acid is an organic compound containing an imidazole ring and a carboxyl group. 1H-Imidazole-4-carboxylic acid stabilizes specific forms of metal ions through coordination, thus influencing the progress of chemical reactions. 1H-Imidazole-4-carboxylic acid plays an important role in the hydrolysis of phosphate esters catalyzed by lanthanide metals. 1H-Imidazole-4-carboxylic acid can be used to modify dendrimers, changing the surface properties and catalytic performance of materials .
|
-
- HY-W129533
-
|
|
Biochemical Assay Reagents
|
Others
|
|
tert-Butyl 1H-indol-4-ylcarbamate is a nucleophilic reagent. tert-Butyl 1H-indol-4-ylcarbamate induces the formation of the stable triple hydrogen-bonded complex A-TS-Re. tert-Butyl 1H-indol-4-ylcarbamate undergoes Friedel-Crafts reactions with β,γ-unsaturated α-ketiminoesters .
|
-
- HY-W004645R
-
|
|
Reference Standards
|
|
|
(E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate (Standard) is the analytical standard of (E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate. This product is intended for research and analytical applications.
|
-
- HY-20821R
-
|
|
Reference Standards
|
|
|
6-Chloro-1-methylpyrimidine-2,4(1H,3H)-dione (Standard) is the analytical standard of 6-Chloro-1-methylpyrimidine-2,4(1H,3H)-dione. This product is intended for research and analytical applications.
|
-
- HY-100040R
-
|
4-Ethoxycarbonylpyrazole (Standard)
|
Biochemical Assay Reagents
Reference Standards
|
Others
|
|
Ethyl 1H-pyrazole-4-carboxylate (Standard) is the analytical standard of Ethyl 1H-pyrazole-4-carboxylate (HY-100040). This product is intended for research and analytical applications. 4-Ethoxycarbonylpyrazole is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
- HY-W128112
-
|
alpha-D-Ribofuranoside,2,4(1H,3H)-pyrimidinedione-1
|
Nucleoside Antimetabolite/Analog
|
Cancer
|
|
1-(a-D-ribofuranosyl)uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-65092R
-
|
|
Reference Standards
|
|
|
6-Chloro-1,3,5-triazine-2,4(1H,3H)-dione (Standard) is the analytical standard of 6-Chloro-1,3,5-triazine-2,4(1H,3H)-dione. This product is intended for research and analytical applications.
|
-
- HY-W014109
-
|
(E)-5-(2-Bromovinyl)uracil; BVU
|
DNA/RNA Synthesis
|
Infection
|
|
(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) that may be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner. It enhances the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil (HY-90006) in a P388 murine leukemia model when administered at a dose of 200 μmol/kg, increasing survival time.
|
-
- HY-W543284
-
|
|
MOFs
|
Others
|
|
1H-Benzimidazole,4,7-di-4-carboxyphenyl is a metal-organic framework (MOF).
|
-
- HY-I0314
-
|
|
Drug Intermediate
|
Others
|
|
1H-Pyrazole-4-boronic acid pinacol ester is a drug intermediate that can be used for the synthesis of Mps1 kinase inhibitors .
|
-
- HY-W340583S
-
-
- HY-162130
-
|
|
Bacterial
|
Infection
|
|
Antibacterial agent 176 (Compound 6f) is a potent PqsR antagonist. Antibacterial agent 176 has a good inhibitory effect on P. aeruginosa CF, and a significant inhibitory effect on the production of pyocyanin, 2-alkyl-4 (1H) -quinolones .
|
-
- HY-W002065
-
|
|
Drug Metabolite
Drug Intermediate
|
Cancer
|
|
4-Carboxypyrazole (1H-Pyrazole-4-carboxylic acid) is a metabolite of Fomepizole (HY-B0876). 4-Carboxypyrazole is involved in the synthesis of ALKBH1 inhibitors. 4-Carboxypyrazole can be used in the research of gastric cancer .
|
-
- HY-153757
-
|
|
Reactive Oxygen Species (ROS)
|
Cancer
|
|
Antioxidant agent-11 is a 2-pyrazole-2,3-dihydroquinazolin-4(1H)-one derivative and a weak antioxidant. Antioxidant agent-11 scavenges DPPH free radicals. Antioxidant agent-11 can be used for the research of lung carcinoma .
|
-
- HY-152877
-
|
|
Nucleoside Antimetabolite/Analog
|
Others
|
|
2-Amino-1-β-D-ribofuranosyl-4(1H)-pyrimidinone is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-152878
-
|
NSC 529488
|
Nucleoside Antimetabolite/Analog
|
Others
|
|
2-Amino-1-β-D-arabinofuranosyl-4(1H)-pyrimidinone is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-W766242
-
|
|
Isotope-Labeled Compounds
|
Others
|
|
1'-Epi 3,5-Dibenzoate-2,2-difluorouridine- 13C, 15N2 is the 13C- and 15N-labeled 1-(3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-α-D-erythro-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione (HY-W778177).
|
-
- HY-75975
-
|
1H-Isoindole-1,3(2H)-dione,2-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl
|
Drug Intermediate
|
Others
|
|
(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione (1H-Isoindole-1,3(2H)-dione,2-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl) is a drug intermediate for synthesis of various active compounds.
|
-
- HY-W777759
-
|
4-Amino-6-hydroxy-2-mercapto-5-nitrosopyrimidine-13C,15N
|
Isotope-Labeled Compounds
|
Others
|
|
6-Amino-5-nitroso-2-thiouracil- 13C, 15N (4-Amino-6-hydroxy-2-mercapto-5-nitrosopyrimidine- 13C, 15N) is the 13C- and 15N-labeled 6-Amino-5-nitroso-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (HY-75602).
|
-
- HY-108239
-
|
|
Histone Methyltransferase
Autophagy
|
Cancer
|
|
BIX-01294 trihydrochloride is a reversible and highly selective G9a and GLP Histone Methyltransferase inhibitor, with IC50s of of 1.7 μM and 0.9 μM, respectively. BIX-01294 trihydrochloride inhibits G9a/GLP by competing for binding with the amino acids N-terminal of the substrate lysine residue. BIX-01294 trihydrochloride, a (1H-1,4-diazepin-1-yl)-quinazolin-4-yl amine derivative, induces necroptosis and autophagy. BIX-01294 trihydrochloride has antitumor activity in recurrent tumor cells .
|
-
- HY-10587
-
|
|
Histone Methyltransferase
Autophagy
|
Cancer
|
|
BIX-01294 is a reversible and highly selective G9a and GLP Histone Methyltransferase inhibitor, with IC50s of of 1.7 μM and 0.9 μM, respectively. BIX-01294 inhibits G9a/GLP by competing for binding with the amino acids N-terminal of the substrate lysine residue. BIX-01294, a (1H-1,4-diazepin-1-yl)-quinazolin-4-yl amine derivative, induces necroptosis and autophagy. BIX-01294 has antitumor activity in recurrent tumor cells .
|
-
- HY-W377455
-
|
|
Nucleoside Antimetabolite/Analog
|
Others
|
|
5-Fluoro-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione (2',5-difluoro-2'-deoxy-1-arabinosyluracil) is a uridine analogue. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents .
|
-
- HY-10587R
-
|
|
Reference Standards
Histone Methyltransferase
Autophagy
|
Cancer
|
|
BIX-01294 (Standard) is the analytical standard of BIX-01294 (HY-10587). This product is intended for research and analytical applications. BIX-01294 is a reversible and highly selective G9a and GLP Histone Methyltransferase inhibitor, with IC50s of of 1.7 μM and 0.9 μM, respectively. BIX-01294 inhibits G9a/GLP by competing for binding with the amino acids N-terminal of the substrate lysine residue. BIX-01294, a (1H-1,4-diazepin-1-yl)-quinazolin-4-yl amine derivative, induces necroptosis and autophagy. BIX-01294 has antitumor activity in recurrent tumor cells .
|
-
- HY-108239R
-
|
|
Reference Standards
Histone Methyltransferase
Autophagy
|
Cancer
|
|
BIX-01294 trihydrochloride (Standard) is the analytical standard of BIX-01294 (trihydrochloride) (HY-108239). This product is intended for research and analytical applications. BIX-01294 trihydrochloride is a reversible and highly selective G9a and GLP Histone Methyltransferase inhibitor, with IC50s of of 1.7 μM and 0.9 μM, respectively. BIX-01294 trihydrochloride inhibits G9a/GLP by competing for binding with the amino acids N-terminal of the substrate lysine residue. BIX-01294 trihydrochloride, a (1H-1,4-diazepin-1-yl)-quinazolin-4-yl amine derivative, induces necroptosis and autophagy. BIX-01294 trihydrochloride has antitumor activity in recurrent tumor cells .
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-W007695
-
|
4-Imidazolecarboxylic acid
|
Biochemical Assay Reagents
|
|
1H-Imidazole-4-carboxylic acid is an organic compound containing an imidazole ring and a carboxyl group. 1H-Imidazole-4-carboxylic acid stabilizes specific forms of metal ions through coordination, thus influencing the progress of chemical reactions. 1H-Imidazole-4-carboxylic acid plays an important role in the hydrolysis of phosphate esters catalyzed by lanthanide metals. 1H-Imidazole-4-carboxylic acid can be used to modify dendrimers, changing the surface properties and catalytic performance of materials .
|
-
- HY-I0314
-
|
|
Biochemical Assay Reagents
|
|
1H-Pyrazole-4-boronic acid pinacol ester is a drug intermediate that can be used for the synthesis of Mps1 kinase inhibitors .
|
-
- HY-78248
-
|
|
Biochemical Assay Reagents
|
|
4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
- HY-100040R
-
|
4-Ethoxycarbonylpyrazole (Standard)
|
Biochemical Assay Reagents
|
|
Ethyl 1H-pyrazole-4-carboxylate (Standard) is the analytical standard of Ethyl 1H-pyrazole-4-carboxylate (HY-100040). This product is intended for research and analytical applications. 4-Ethoxycarbonylpyrazole is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
| Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
| Cat. No. |
Product Name |
Chemical Structure |
-
- HY-W741652
-
|
|
|
2-(2-Chloroethyl-d4)-1H-isoindole-1,3-dione is the deuterium labeled 2-(2-Chloroethyl)isoindoline-1,3-dione (HY-W014424).
|
-
-
- HY-154741S
-
|
|
|
6-β-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione- 15N2 is 15N labeled (HY-154741).
|
-
-
- HY-W555382S
-
|
|
|
Pseudane IX-d4 (2-Nonylquinolin-4(1H)-one-d4) is deuterium labeled Pseudane IX. Pseudane IX, a compound isolated from the leaves of Ruta angustifolia, has strong anti-HCV activity with an IC50 value of 1.4 μg/mL. Pseudane IX reduces HCV RNA replication and viral protein synthesis levels .
|
-
-
- HY-W751834
-
|
|
|
6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione- 13C3 (NSC 99321- 13C3) is the 13C-labeled 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione (HY-W016913).
|
-
-
- HY-W768482
-
|
|
|
2-Amino-6-hydroxypyrimidin-4(1H)-one- 13C2 (2-Amino-6-hydroxy-1H-pyrimidin-4-one- 13C2) is the 13C-labeled 2-Amino-6-hydroxypyrimidin-4(1H)-one (HY-Y0559).
|
-
-
- HY-W701580
-
|
|
|
6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione-d3 (6-Amino-3-methyluracil-d3) is the deuterium labeled 6-Amino-3-methylpyrimidine-2,4(1H,3H)-dione (HY-W038777).
|
-
-
- HY-W340583S
-
|
|
|
(2-(1H-indol-3-yl)acetyl)-L-leucine-d4 is deuterium labeled (2-(1H-indol-3-yl)acetyl)-L-leucine .
|
-
-
- HY-W766242
-
|
|
|
1'-Epi 3,5-Dibenzoate-2,2-difluorouridine- 13C, 15N2 is the 13C- and 15N-labeled 1-(3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-α-D-erythro-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione (HY-W778177).
|
-
-
- HY-W777759
-
|
|
|
6-Amino-5-nitroso-2-thiouracil- 13C, 15N (4-Amino-6-hydroxy-2-mercapto-5-nitrosopyrimidine- 13C, 15N) is the 13C- and 15N-labeled 6-Amino-5-nitroso-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (HY-75602).
|
-
| Cat. No. |
Product Name |
|
Classification |
-
- HY-152877
-
|
|
|
Nucleoside Analogs
Cytidine
|
|
2-Amino-1-β-D-ribofuranosyl-4(1H)-pyrimidinone is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-154325
-
|
|
|
Nucleoside Analogs
|
|
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-4(1H)-pyrimidinone is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-152603
-
|
|
|
Nucleoside Analogs
|
|
2-Amino-1-β-D-arabinofuranosyl-5-methyl-4(1H)-pyrimidinone is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-152853
-
|
|
|
Nucleoside Analogs
|
|
3-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-154663
-
|
|
|
Nucleoside Analogs
|
|
1-β-D-Arabinofuranosyl-5-bromo-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-154335
-
|
|
|
Nucleoside Analogs
|
|
1-(3-Deoxy-3-fluoro-β-D-xylofuranosyl)-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-152676
-
|
|
|
Nucleoside Analogs
|
|
1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethyl-2,4(1H,3H)-pyrimidinedione is a thymidine analogue. Analogs of this series have insertional activity towards replicated DNA. They can be used to label cells and track DNA synthesis .
|
-
- HY-154652
-
|
|
|
Nucleoside Analogs
|
|
1-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents .
|
-
- HY-154613
-
|
|
|
Nucleoside Analogs
|
|
(2R-cis)-5-[Tetrahydro-5-(hydroxymethyl)-4-oxo-2-furanyl]-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
-
- HY-152878
-
|
NSC 529488
|
|
Nucleoside Analogs
Cytidine
|
|
2-Amino-1-β-D-arabinofuranosyl-4(1H)-pyrimidinone is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: